Novo Nordisk A/S (NVO)
49.12
-0.25
(-0.51%)
USD |
NYSE |
Feb 10, 16:00
49.10
-0.02
(-0.04%)
After-Hours: 20:00
Novo Nordisk Accounts Payable (Quarterly) : 3.107B for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Ascendis Pharma A/S | 92.36M |
| Evaxion AS | -- |
| Regeneron Pharmaceuticals, Inc. | 939.00M |
| Viking Therapeutics, Inc. | 4.413M |
| DBV Technologies SA | 39.82M |